|
PRKAA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.24739999999946E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.341330E-03 |
| Normal-vs-Stage2 |
1.038980E-01 |
| Normal-vs-Stage3 |
1.27739999999932E-06 |
| Normal-vs-Stage4 |
3.16490000873415E-09 |
| Stage1-vs-Stage2 |
8.441800E-01 |
| Stage1-vs-Stage3 |
1.009730E-02 |
| Stage1-vs-Stage4 |
5.91759999999386E-05 |
| Stage2-vs-Stage3 |
1.527810E-01 |
| Stage2-vs-Stage4 |
3.286400E-02 |
| Stage3-vs-Stage4 |
1.997800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.038440E-04 |
| Normal-vs-AfricanAmerican |
9.15429999581718E-08 |
| Normal-vs-Asian |
6.100600E-01 |
| Caucasian-vs-AfricanAmerican |
4.759400E-03 |
| Caucasian-vs-Asian |
3.644200E-01 |
| AfricanAmerican-vs-Asian |
2.567800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5428000000004E-05 |
| Normal-vs-Female |
2.025800E-04 |
| Male-vs-Female |
6.102800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.421500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.246000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.7673799999951E-05 |
| Normal-vs-Age(81-100Yrs) |
3.658900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.117400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.450600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.737600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.811000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.935600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.709800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.593800E-01 |
| Normal-vs-Grade 2 |
1.904350E-02 |
| Normal-vs-Grade 3 |
1.477000000083E-08 |
| Normal-vs-Grade 4 |
1.36419764373841E-11 |
| Grade 1-vs-Grade 2 |
4.054800E-01 |
| Grade 1-vs-Grade 3 |
6.697700E-03 |
| Grade 1-vs-Grade 4 |
5.65229999999195E-05 |
| Grade 2-vs-Grade 3 |
7.211900E-04 |
| Grade 2-vs-Grade 4 |
1.28649999542318E-08 |
| Grade 3-vs-Grade 4 |
8.637300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.748820E-01 |
| Normal-vs-ccB subtype |
3.1796999999667E-07 |
| ccA subtype-vs-ccB subtype |
3.98509999999241E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.032300E-04 |
| Normal-vs-N1 |
2.631200E-04 |
| N0-vs-N1 |
9.748400E-02 |
|
|
